The string sign is a narrow thread of contrast material visible on imaging as it passes through a severely narrowed segment of bowel, and it has been one of the most recognizable radiological hallmarks of Crohn’s disease for decades. First described on barium follow-through studies, the sign typically appears in the terminal ileum, where Crohn’s inflammation most commonly strikes. While modern imaging has largely replaced barium studies, the string sign remains a clinically meaningful indicator of stricturing disease and often signals a turning point in how aggressively a patient’s Crohn’s needs to be managed.
What the String Sign Looks Like and What It Means
On a traditional barium small-bowel study, the string sign appears as a thin, pencil-line column of barium squeezing through a long, tight segment of intestine. The surrounding bowel may look relatively normal, which makes the abrupt narrowing all the more striking. The sign gets its name from the obvious visual comparison: the barium column looks like a piece of string rather than the wider tube you’d expect from a healthy bowel loop. On CT enterography, the modern workhorse for Crohn’s imaging, the same phenomenon shows up as a segment of bowel with markedly thickened walls, a pinched lumen, and sometimes dilation of the intestine upstream from the blockage, where contents are backing up behind the narrowing.
The sign is not just a radiological curiosity. It tells the clinical team that the affected bowel segment has progressed beyond surface-level inflammation into a stricture, a structural narrowing that can partially or completely block the passage of food and fluid. A stricture severe enough to produce a string sign often causes symptoms like cramping abdominal pain after eating, bloating, nausea, and in some cases vomiting. Some patients learn to avoid high-fiber or bulky foods because those are more likely to get caught at the narrowed segment.
Why the Bowel Narrows in Crohn’s Disease
Crohn’s disease is unusual among inflammatory bowel conditions because it affects the full thickness of the intestinal wall, not just the inner lining. Over time, repeated cycles of inflammation and healing can cause the wall to thicken with scar tissue, gradually shrinking the internal diameter of the bowel. This process doesn’t happen overnight. Many patients live with Crohn’s for years before a stricture develops, though for others it can appear early in the disease course.
Not all strictures are the same, and the distinction matters for treatment. Some are predominantly inflammatory, meaning the narrowing is caused by active swelling, immune-cell infiltration, and edema in the bowel wall. Others are predominantly fibrotic, meaning scar tissue and collagen deposits have stiffened and thickened the wall. Most real-world strictures are a mix of both, which is one reason they can be so tricky to manage. Research using advanced MRI techniques has shown that diffusion-weighted imaging can help distinguish between these two types, because inflammatory tissue and fibrotic tissue restrict water movement differently.1Radiology of Infectious Diseases. Identifying the inflammatory and fibrotic bowel stricture: MRI diffusion-weighted imaging in Crohn’s disease This distinction is clinically important because inflammatory strictures may respond to medication, while fibrotic ones generally do not.
Can the String Sign Appear in Conditions Other Than Crohn’s?
Though the string sign is strongly associated with Crohn’s disease, it is not exclusive to it. Any process that severely narrows a segment of bowel can produce a similar appearance on imaging. Intestinal tuberculosis is one of the most discussed mimics in the medical literature, particularly in parts of the world where TB is common. Both Crohn’s and intestinal TB can cause inflammation, strictures, and even fistulas in the terminal ileum, and distinguishing them on imaging alone can be genuinely difficult.2Europe PMC. Intestinal tuberculosis versus crohn’s disease: Clinical and radiological recommendations Other causes of bowel strictures include radiation damage from cancer treatment, certain medications (particularly potassium chloride tablets and nonsteroidal anti-inflammatory drugs taken chronically), and, rarely, small-bowel tumors. Context is everything: a string sign in a young patient with a history of chronic diarrhea and perianal disease points strongly toward Crohn’s, while the same finding in someone recently treated for abdominal or pelvic cancer might suggest radiation injury.
Medical Treatment for Stricturing Crohn’s
For a long time, the appearance of a stricture was treated almost as an automatic ticket to surgery. That thinking has shifted considerably. If a stricture is caught while it still has a significant inflammatory component, medications that target the underlying inflammation can sometimes open the bowel back up, or at least prevent the stricture from worsening. Biologic therapies, particularly anti-TNF drugs like infliximab and adalimumab, have shown real benefit in this setting. In one large real-world analysis, about 69% of patients with stricturing Crohn’s treated with anti-TNF therapy had treatment success at 12 months without needing additional interventions. That number dropped to roughly 28% at five years, mostly because the drugs gradually lost effectiveness rather than because of safety problems.3Scientific Reports. Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease
Those numbers paint a realistic picture: biologics can buy substantial time and keep patients out of the operating room, but they are not a permanent fix for most people with stricturing disease. A systematic review of clinical trials in stricturing Crohn’s found that biologic therapy was generally associated with clinical improvement and, in selected groups, reduced the need for surgery, but the response was notably weaker when the stricture was tight enough that nothing could pass through it.4PubMed. The missing evidence: Stricturing Crohn’s disease in clinical trials, a systematic review Emerging evidence also suggests that biologics and immunomodulators may have some effect even on strictures with heavy collagen deposition, potentially slowing the fibrotic process and reducing long-term bowel damage.5Journal of Crohn’s and Colitis. The Role of Immunomodulators and Biologics in the Medical Management of Stricturing Crohn’s Disease The evidence there is less robust, but it challenges the old assumption that once fibrosis sets in, drugs are useless.
Endoscopic Balloon Dilation
When a stricture is short and accessible by endoscope, inflating a balloon inside the narrowed segment to physically stretch it open has become a well-established first-line option. Endoscopic balloon dilation avoids the risks and recovery time of surgery, and for many patients it can be repeated as needed over years. The procedure is particularly effective for strictures at the site of a previous surgical connection, where the bowel was rejoined after a resection.6PubMed Central. Endoscopic Balloon Dilation for Crohn’s Disease-Associated Strictures
A systematic review pooling data from multiple studies found that about 27% of patients who underwent balloon dilation eventually needed surgery over follow-up periods ranging from about one to nearly six years. That rate was somewhat lower for strictures at surgical anastomoses (around 18%) compared with primary strictures that formed on their own (around 29%). Stricture length mattered: when the narrowed segment was shorter than four centimeters, patients were significantly less likely to need surgery afterward. Serious complications, including perforation or significant bleeding, occurred in about 4% of procedures.7PubMed. Endoscopic balloon dilation in the management of strictures in Crohn’s disease: a systematic review and meta-analysis of non-randomized trials Those are fairly reassuring numbers, though they underscore that dilation works best for short, accessible strictures and is less suited to the long, tight narrowings that produce a classic string sign.
More recently, balloon-assisted enteroscopy has made it possible to reach strictures deeper in the small bowel that a standard colonoscope cannot access. The evidence for this approach is still limited, but early results suggest it may become a viable alternative to surgery for certain small-bowel strictures.8Intestinal Research. Current status of endoscopic balloon dilation for Crohn’s disease
When Surgery Becomes Necessary
Despite the expanding toolkit of medical and endoscopic options, surgery remains necessary for many patients with stricturing Crohn’s, particularly when the narrowing is long, fibrotic, or complicated by abscesses or fistulas. The two main surgical approaches are resection (cutting out the diseased segment and reconnecting the healthy ends) and stricturoplasty (cutting into the narrowed area and reshaping it to widen the lumen without removing bowel). Stricturoplasty is generally favored for patients with multiple short strictures or those who have already lost significant bowel length from previous surgeries, since it conserves intestinal tissue.9Gastroenterology. Management of Small Bowel Crohn’s Disease Strictures: To Cut, to Stretch, or to Treat Inflammation?
For strictures in the terminal ileum specifically, which is where the string sign most commonly appears, ileocolic resection (removing the end of the small bowel and the first part of the colon, then reconnecting them) is the standard procedure. A comparison of ileocecal stricturoplasty versus resection in Crohn’s patients found no significant differences in long-term outcomes or clinical relapse between the two approaches.10PubMed. Ileocecal strictureplasty for Crohn’s disease: long-term results and comparison with ileocecal resection That finding gives surgeons flexibility to choose based on the individual patient’s anatomy and disease pattern rather than defaulting to one technique. One important caveat: stricturoplasty is generally not performed when there are complications like abscesses or fistulas around the diseased segment, because reshaping compromised tissue without removing it carries a higher risk of breakdown.
Preserving bowel length is a real concern for patients who face multiple operations over a lifetime. Each resection removes a piece of intestine that does not grow back, and losing too much small bowel can lead to short bowel syndrome, a serious condition where the remaining intestine cannot absorb enough nutrients to sustain health. This risk is one of the main motivations for trying medical therapy, dilation, and stricturoplasty before resorting to resection whenever possible.
Strictures in Children and Adolescents
Crohn’s disease often begins in childhood or adolescence, and stricturing disease in young patients carries its own set of concerns. Growth, puberty, nutrition, and quality of life all factor into treatment decisions in ways that differ from adult care. A retrospective study from a large pediatric hospital examined 44 children with stricturing ileal Crohn’s and found that about 68% required surgery, with a median time of roughly three months between stricture diagnosis and the operating room. The strictures in these patients had a median length of seven centimeters, with the bowel lumen narrowed to a mere two millimeters at its tightest point.11PubMed. Imaging and clinical predictors of surgery in stricturing ileal Crohn’s disease: a retrospective study from a large pediatric hospital Those numbers help explain why so many of these patients ended up needing surgery: a lumen that narrow leaves very little room for food to pass, and the stricture lengths were too long for balloon dilation to be a realistic first option.
For pediatric patients in particular, the tension between controlling disease and preserving growth makes treatment planning a balancing act. Aggressive immunosuppression can control inflammation but may affect bone development, while repeated surgeries remove bowel length during a period of life when nutritional demands are at their highest. Nutritional therapy, discussed below, has a particularly strong track record in children and is sometimes used as a first-line treatment to reduce inflammation and improve strictures before committing to surgery or long-term biologic therapy.
Tracking Strictures Without Repeat Imaging
Patients with stricturing Crohn’s often undergo frequent imaging to assess whether their narrowing is stable, improving, or getting worse. But repeated CT scans carry cumulative radiation exposure, and MRI, while radiation-free, is expensive and not always immediately available. This has pushed interest in non-invasive markers that can track disease activity between imaging studies. Fecal calprotectin, a protein released by white blood cells in inflamed bowel tissue, has emerged as a useful tool. Its level in stool correlates with the severity of small-bowel Crohn’s disease as measured by CT enterography, providing a reasonably reliable way to monitor inflammation without another scan.12PubMed. Level of Fecal Calprotectin Correlates With Severity of Small Bowel Crohn’s Disease, Measured by Balloon-assisted Enteroscopy and Computed Tomography Enterography
Calprotectin has limits, though. It reflects inflammation, not fibrosis. A patient with a predominantly scarred, fibrotic stricture might have a normal calprotectin level while still having significant narrowing. So a low calprotectin result in a patient with known stricturing disease is reassuring about inflammation but doesn’t mean the stricture itself has resolved. Most clinicians use calprotectin as one piece of a larger puzzle, alongside symptoms, blood markers, and periodic imaging.
Exclusive Enteral Nutrition for Bowel Strictures
One of the more surprising approaches to managing Crohn’s strictures involves replacing all regular food with a liquid formula diet for a defined period, typically around 12 weeks. This strategy, known as exclusive enteral nutrition, is better known as a tool for inducing remission in newly diagnosed Crohn’s, especially in children. But research has shown it can also improve established strictures. In a study of 59 patients who completed a full course of exclusive enteral nutrition for inflammatory bowel strictures, about 81% achieved symptomatic remission and roughly 65% reached clinical remission. Perhaps most strikingly, the average cross-sectional area of the bowel at the stricture site increased by approximately 331% over 12 weeks, measured on imaging before and after treatment.13Journal of Clinical Gastroenterology. Exclusive Enteral Nutritional Therapy Can Relieve Inflammatory Bowel Stricture in Crohn’s Disease
Those results are dramatic, though they come with context. About 15% of the patients in that study developed progressive bowel obstruction during treatment and required surgery, so this is not a risk-free approach. The patients whose strictures improved likely had a significant inflammatory component that responded to the anti-inflammatory effects of bowel rest and formula feeding. Patients with heavily scarred, fibrotic strictures are less likely to see the same benefit. Still, for patients who want to avoid or delay surgery, especially adolescents and young adults for whom bowel preservation is a high priority, exclusive enteral nutrition represents a genuine option that many patients have never heard of. Compliance is the main practical barrier: drinking nothing but formula for three months is monotonous and socially isolating, and motivation tends to flag around the halfway mark.
The String Sign in the Era of Modern Imaging
Classical barium studies, which gave us the string sign in the first place, are now rarely performed in most Western hospitals. CT enterography and MR enterography have largely taken over, offering far more detailed information about the bowel wall, surrounding fat, and complications like abscesses or fistulas that barium studies could not reliably detect. On these modern imaging modalities, the equivalent of the string sign shows up as a segment of severely thickened bowel wall with a barely visible lumen, often with upstream dilation and sometimes with the characteristic “creeping fat” of mesenteric tissue wrapping around the inflamed segment.
Despite the shift in technology, the term “string sign” persists in clinical conversation and in case reports describing Crohn’s-related strictures.14ScienceDirect / Revista de Gastroenterología de México (English Edition). The string sign in Crohn’s disease It has become shorthand for a degree of luminal narrowing severe enough to warrant escalation of treatment, whether that means starting biologics, planning balloon dilation, or consulting a surgeon. For patients, hearing that their imaging shows a string sign can be alarming, but understanding that it represents one point on a spectrum of stricturing disease, and that multiple treatment options exist at every stage, can help put the finding in perspective.